BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO
Name
As of 12/19/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
2.3%
1 yr return
4.2%
3 Yr Avg Return
0.1%
5 Yr Avg Return
5.2%
Net Assets
$8.02 B
Holdings in Top 10
46.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.86%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 19.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/19/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
SHSCX - Profile
Distributions
- YTD Total Return 2.3%
- 3 Yr Annualized Total Return 0.1%
- 5 Yr Annualized Total Return 5.2%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.77%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameBLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO
-
Fund Family NameBlackRock
-
Inception DateOct 28, 2002
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerErin Xie
Fund Description
SHSCX - Performance
Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.3% | -27.8% | 19.0% | 52.83% |
1 Yr | 4.2% | -27.8% | 18.5% | 52.20% |
3 Yr | 0.1%* | -28.3% | 7.9% | 40.13% |
5 Yr | 5.2%* | -11.6% | 11.4% | 50.34% |
10 Yr | 6.5%* | -0.5% | 12.6% | 52.21% |
* Annualized
Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -1.6% | -12.6% | 19.0% | 76.10% |
2022 | -14.4% | -53.9% | 3.2% | 71.05% |
2021 | 0.5% | -39.6% | 24.2% | 49.34% |
2020 | 13.5% | -13.6% | 178.2% | 53.69% |
2019 | 19.3% | 3.8% | 63.8% | 64.66% |
Total Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.3% | -27.8% | 19.0% | 52.83% |
1 Yr | 4.2% | -27.8% | 18.5% | 52.20% |
3 Yr | 0.1%* | -28.3% | 7.9% | 40.13% |
5 Yr | 5.2%* | -11.6% | 11.4% | 50.34% |
10 Yr | 6.5%* | -0.5% | 12.6% | 52.21% |
* Annualized
Total Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 2.8% | -12.6% | 19.0% | 73.58% |
2022 | -6.6% | -53.9% | 3.7% | 29.61% |
2021 | 10.9% | -33.9% | 26.0% | 41.45% |
2020 | 18.6% | -0.7% | 180.6% | 64.43% |
2019 | 24.4% | 4.6% | 63.8% | 62.41% |
NAV & Total Return History
SHSCX - Holdings
Concentration Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Assets | 8.02 B | 6.43 M | 45.7 B | 5.66% |
Number of Holdings | 136 | 25 | 430 | 10.69% |
Net Assets in Top 10 | 4.08 B | 2.55 M | 23.9 B | 6.92% |
Weighting of Top 10 | 46.66% | 18.9% | 78.1% | 46.54% |
Top 10 Holdings
- UNITEDHEALTH GROUP INC 9.27%
- ELI LILLY CO 8.20%
- BOSTON SCIENTIFIC CORP 5.73%
- AMGEN INC 3.94%
- THERMO FISHER SCIENTIFIC INC 3.64%
- INTUITIVE SURGICAL INC 3.42%
- Danaher Corp 3.35%
- AbbVie Inc 3.35%
- ELEVANCE HEALTH INC 2.99%
- STRYKER CORP 2.77%
Asset Allocation
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Stocks | 97.41% | 89.92% | 106.13% | 62.26% |
Cash | 4.01% | 0.00% | 33.01% | 27.67% |
Bonds | 0.02% | 0.00% | 12.39% | 22.01% |
Preferred Stocks | 0.01% | 0.00% | 7.86% | 29.56% |
Other | 0.00% | -22.99% | 23.24% | 32.70% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 35.71% |
Stock Sector Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Healthcare | 98.96% | 59.26% | 100.00% | 74.68% |
Basic Materials | 0.73% | 0.00% | 7.16% | 14.29% |
Financial Services | 0.31% | 0.00% | 1.60% | 7.14% |
Utilities | 0.00% | 0.00% | 0.00% | 31.82% |
Technology | 0.00% | 0.00% | 22.69% | 38.31% |
Real Estate | 0.00% | 0.00% | 5.89% | 34.42% |
Industrials | 0.00% | 0.00% | 7.02% | 37.01% |
Energy | 0.00% | 0.00% | 0.00% | 31.82% |
Communication Services | 0.00% | 0.00% | 9.11% | 35.06% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 40.26% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 35.71% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
US | 94.34% | 61.27% | 104.41% | 49.69% |
Non US | 3.06% | 0.00% | 34.10% | 44.03% |
Bond Sector Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Cash & Equivalents | 4.01% | 0.00% | 100.00% | 27.04% |
Derivative | 0.00% | -0.01% | 23.24% | 15.72% |
Securitized | 0.00% | 0.00% | 0.00% | 31.88% |
Corporate | 0.00% | 0.00% | 81.57% | 42.03% |
Municipal | 0.00% | 0.00% | 0.00% | 31.88% |
Government | 0.00% | 0.00% | 29.44% | 32.61% |
Bond Geographic Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
US | 0.02% | 0.00% | 11.75% | 22.01% |
Non US | 0.00% | 0.00% | 3.33% | 32.70% |
SHSCX - Expenses
Operational Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.86% | 0.08% | 4.48% | 20.13% |
Management Fee | 0.67% | 0.03% | 1.25% | 47.17% |
12b-1 Fee | 1.00% | 0.00% | 1.00% | 84.42% |
Administrative Fee | 0.07% | 0.03% | 0.25% | 18.92% |
Sales Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | 1.00% | 1.00% | 1.00% | 40.00% |
Trading Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 14.07% |
SHSCX - Distributions
Dividend Yield Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.24% | 58.49% |
Dividend Distribution Analysis
SHSCX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annual | Quarterly | Quarterly |
Net Income Ratio Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.77% | -2.54% | 1.85% | 82.24% |
Capital Gain Distribution Analysis
SHSCX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 11, 2024 | $3.092 | CapitalGainLongTerm |
Jul 18, 2024 | $2.491 | CapitalGainLongTerm |
Dec 07, 2023 | $1.000 | CapitalGainLongTerm |
Jul 20, 2023 | $1.342 | CapitalGainLongTerm |
Jul 14, 2022 | $4.659 | CapitalGainLongTerm |
Dec 07, 2021 | $4.014 | OrdinaryDividend |
Jul 15, 2021 | $2.294 | OrdinaryDividend |
Dec 07, 2020 | $2.751 | OrdinaryDividend |
Dec 05, 2019 | $2.297 | CapitalGainLongTerm |
Dec 06, 2018 | $0.006 | CapitalGainShortTerm |
Dec 06, 2018 | $4.147 | CapitalGainLongTerm |
Dec 04, 2017 | $1.894 | CapitalGainLongTerm |
Dec 06, 2016 | $1.081 | CapitalGainLongTerm |
Dec 12, 2014 | $1.461 | CapitalGainShortTerm |
Dec 12, 2014 | $1.713 | CapitalGainLongTerm |
Dec 13, 2013 | $2.179 | CapitalGainShortTerm |
Dec 13, 2013 | $1.648 | CapitalGainLongTerm |
Dec 12, 2012 | $0.674 | CapitalGainShortTerm |
Dec 12, 2012 | $1.478 | CapitalGainLongTerm |
Dec 08, 2011 | $1.256 | CapitalGainLongTerm |
Dec 08, 2011 | $0.042 | CapitalGainShortTerm |
Dec 09, 2010 | $0.309 | CapitalGainShortTerm |
Dec 09, 2010 | $0.749 | CapitalGainLongTerm |
Dec 11, 2008 | $0.548 | CapitalGainShortTerm |
Dec 11, 2008 | $1.622 | CapitalGainLongTerm |
Dec 06, 2007 | $0.435 | CapitalGainShortTerm |
Dec 06, 2007 | $0.453 | CapitalGainLongTerm |
Dec 07, 2006 | $0.349 | CapitalGainLongTerm |
Dec 08, 2005 | $0.269 | CapitalGainShortTerm |
Dec 08, 2005 | $0.346 | CapitalGainLongTerm |
Jun 23, 2005 | $0.010 | CapitalGainLongTerm |
SHSCX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
18.85
18.9%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.88 | 0.25 |